NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Morton SC, Adams JL, Suttorp MJ, et al. Meta-regression Approaches: What, Why, When, and How? Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Mar. (Technical Reviews, No. 8.)

Cover of Meta-regression Approaches

Meta-regression Approaches: What, Why, When, and How?

Show details

Bibliography

1.
Aitkin M. Meta-analysis by random effect modelling in generalized linear models. Stat Med. 1999 Sep;18(1718):2343–51. [PubMed: 10474144]
2.
Allison DB, Mentore JL, Heo M. et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry. 1999 Nov;156(11):1686–96. [PubMed: 10553730]
3.
Arends LR, Hoes AW, Lubsen J. et al. Baseline risk as predictor of treatment benefit: three clinical meta-re-analyses. Stat Med. 2000 Dec;19(24):3497–518. [PubMed: 11122510]
4.
Barza M, Ioannidis JP, Cappelleri JC. et al. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ. 1996 Feb;312(7027):338–45. [PMC free article: PMC2350289] [PubMed: 8611830]
5.
Becker BJ, Schram CM. Examining Explanatory Models Through Research Synthesis. In: Cooper H, Hedges LV, editors. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994. p. 357–81.
6.
Berkey CS, Hoaglin DC, Mosteller F. et al. A random-effects regression model for meta-analysis. Stat Med. 1995 Feb;14(4):395–411. [PubMed: 7746979]
7.
Berkey CS, Anderson JJ, Hoaglin DC. Multiple-outcome meta-analysis of clinical trials. Stat Med. 1996 Mar;15(5):537–57. [PubMed: 8668877]
8.
Berkey CS, Hoaglin DC, Antczak-Bouckoms A. et al. Meta-analysis of multiple outcomes by regression with random effects. Stat Med. 1998 Nov;17(22):2537–50. [PubMed: 9839346]
9.
Berlin JA, Longnecker MP, Greenland S. Meta-analysis of Epidemiologic Dose-Response Data. Epidemiology. 1993 May;4(3):218–28. [PubMed: 8512986]
10.
Berlin JA, Antman EM. Advantages and limitations of meta-analytic regressions of clinical trials data. Online J Curr Clin Trials 1994 Jun;Doc No 134. [PubMed: 8199744]
11.
Berlin JA, Santanna J, Schmid CH, et al. Individual Patient versus Group-level Data Meta-regressions for the Investigation of Subgroup Effects: Ecological Bias Rears its Ugly Head. Stat Med 2001. In press. [PubMed: 11813224]
12.
Bucher HC, Griffith LE, Guyatt GH. Systematic review on the risk and benefit of different cholesterol-lowering interventions. Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):187–95. [PubMed: 9974397]
13.
Carroll RJ, Stefanski LA. Measurement error, instrumental variables and corrections for attenuation with applications to meta-analyses. Stat Med. 1994 Jun;13(12):1265–82. [PubMed: 7973207]
14.
Cook RJ, Walter SD. A logistic model for trend in 2 X 2 X K tables with applications to meta-analyses. Biometrics. 1997 Mar;53(1):352–7. [PubMed: 9147599]
15.
Cooper H, Hedges LV, editors. The handbook of research synthesis. New York, NY: Russell Sage Foundation; 1994.
16.
Corrao G, Bagnardi V, Zambon A. et al. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction. 1999 Oct;94(10):1551–73. [PubMed: 10790907]
17.
Daniels MJ, Hughes MD. Meta-analysis for the evaluation of potential surrogate markers. Stat Med. 1997 Sep;16(17):1965–82. [PubMed: 9304767]
18.
DuMouchel WH, Herbert D. Combining information from multiple dose/time/Fractionation studies (Bayesian hierarchical meta-analysis revisited). Proceedings of the 4th International Conf. on Time, Dose and Fractionation in Radiation Oncology; 1993; Madison, WI.
19.
DuMouchel WH, Harris JE. Bayes Methods for Combining the Results of Cancer Studies in Humans and Other Species. JASA. 1983 Jun;78(382):293–308.
20.
DuMouchel WH, Groer PG. A Bayesian methodology for combining radiation studies. 1988. p. 348–66.
21.
DuMouchel WH, Groer PG. A Bayesian methodology for scaling radiation studies from animals to man. Health Phys. 1989;57(Suppl 1):411–8. [PubMed: 2606701]
22.
DuMouchel WH, Waternaux C, Kinney D. Hierarchical Bayesian Linear Models for Assessing the Effect of Extreme Cold Weather on Schizophrenic Births. In: Berry DA, Stangl DK, editors. Bayesian Biostatistics. 1996.
23.
DuMouchel WH. Predictive Cross-Validation of Bayesian Meta-analyses. In: Bernardo JM, Berger JO, Dawid AP, et al., editors. Bayesian Statistics 5. Oxford University Press; 1996. p. 107–27.
24.
DuMouchel WH. Repeated Measures Meta-analysis. Proc. 51st Session International Statistical Institute; 1997; Istanbul, Turkey.
25.
DuMouchel WH, Normand SL. Computer-modeling and Graphical Strategies for Meta-analysis. In: Stangl DK, Berry DB, editors. Meta-analysis in Medicine and Health Policy. 2000. p. 127–78.
26.
Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. Cornwall, UK: BMJ; 2001.
27.
Fay MP, Graubard BI, Freedman LS. et al. Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics. 1998 Mar;54(1):195–208. [PubMed: 9544516]
28.
Freemantle N, Cleland J, Young P. et al. Beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999 Jun;318(7200):1730–7. [PMC free article: PMC31101] [PubMed: 10381708]
29.
Freemantle N, Anderson IM, Young P. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Br J Psychiatry. 2000 Oct;177:292–302. [PubMed: 11116769]
30.
Frost C, Clarke R, Beacon H. Use of hierarchical models for meta-analysis: experience in the metabolic ward studies of diet and blood cholesterol. Stat Med. 1999 Jul;18(13):1657–76. [PubMed: 10407236]
31.
Gareen IF, Greenland S, Horgenstern H. Intrauterine Devices and Pelvic Inflammatory Disease: Meta-analyses of Published Studies, 1974-1990. Epidemiology. 2000 Sep;11(5):589–97. [PubMed: 10955413]
32.
Geddes J, Freemantle N, Harrison P. et al. Atypical antipyschotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000 Dec;321(7273):1371–6. [PMC free article: PMC27538] [PubMed: 11099280]
33.
Gleser LJ, Olkin I. Stochastically Dependent Effect Sizes. In: Cooper H, Olkin I, editors. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994. p. 339–55.
34.
Goldstein H, Yang M. Meta-analysis using multi-level models with an application to the study of class size effects. Applied Statistics. 2000 Apr;49(3):399–412.
35.
Greenland S, Robins J. Invited commentary: ecologic studies—biases, misconceptions, and counterexamples. Am J Epidemiol. 1994 Apr;139(8):747–60. [PubMed: 8178788]
36.
Greenwood CMT, Midgley JP, Matthews AG. et al. Statistical Issues in a Metaregression Analysis of Randomized Trials: Impact on the Dietary Sodium Intake and Blood Pressure Relationship. Biometrics. 1999 Jun;55:630. [PubMed: 11318226]
37.
Hasselblad V. Meta-analysis of multitreatment studies. Med Decis Making. 1998 Jan;18(1):37–43. [PubMed: 9456207]
38.
Hedges LV. A random effects model for effect sizes. Psychol Bull. 1983;93:388–95.
39.
Hedges LV, Olkin I. Regression models in research synthesis. The American Statistician. 1983;37:137–40.
40.
Hedges LV, Olkin I. Statistical methods for meta-analysis. San Diego, CA: Academic Press, Inc.; 1985.
41.
Hedges LV, Vevea JL. Fixed and random-effects models in meta-analysis. Psychological Methods. 1998;3:486–504.
42.
Houghton T, Freemantle N, Cleland JG. Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials. Eur J Heart Fail. 2000 Sep;2(3):333–40. [PubMed: 10938496]
43.
Ioannidis JP, Cappelleri JC, Lau J. et al. Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness. Ann Intern Med. 1995 Jun;122(11):856–66. [PubMed: 7741372]
44.
Ioannidis JP, Lau J. The impact of high-risk patients on the results of clinical trials. J Clin Epidemiol. 1997 Oct;50(10):1089–98. [PubMed: 9368516]
45.
Ioannidis JP, Lau J. Pooling research results: benefits and limitations of meta-analysis. Jt Comm J Qual Improv. 1999 Sep;25(9):462–9. [PubMed: 10481815]
46.
Johnson ES, Lanes SF, Wentworth CE. et al. A metaregression analysis of the dose-response effect of aspirin on stroke. Arch Intern Med. 1999 Jun;159(11):1248–53. [PubMed: 10371234]
47.
Jones DR. Meta-analysis of observational epidemiological studies: a review. J R Soc Med. 1992 Mar;85(3):165–8. [PMC free article: PMC1294821] [PubMed: 1556722]
48.
Kasiske BL, Kalil RS, Ma JZ. et al. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med. 1993 Jan;118(2):129–38. [PubMed: 8416309]
49.
Larholt KM, Gelber RD. Personal communication to Morton SC. 2000. Heterogeneity in meta-analysis: A simulation study of fixed and random effect methods. Available from Dr. AR Sampson.
50.
Larholt KM, Tsiatis AA, Gelber RD. Personal communication to Morton SC. 2000. Variability of Coverage Probabilities When Applying a Random Effects Methodology for Meta-analysis. Available from Dr. AR Sampson.
51.
Larholt KM, Sampson AR. Effects of heteroscedasticity upon certain analyses when regression lines are not parallel. Biometrics. 1995 Jun;51(2):731–7. [PubMed: 7662854]
52.
Levey AS, Schmid CH, Lau J. Antilymphocyte antibodies, renal transplantation, and meta-analysis. Ann Intern Med. 1998 May;128(10):863–5. [PubMed: 9599200]
53.
Li Y, Powers TE, Roth HD. Random-effects linear regression meta-analysis models with application to the nitrogen dioxide health effects studies. Air Waste. 1994 Mar;44(3):261–70. [PubMed: 8055217]
54.
Louis TA, Zelterman D. Bayesian Approaches to Research Synthesis. In: Cooper H, Hedges LV, editors. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 2000. p. 411–22.
55.
McIntosh MW. The population risk as an explanatory variable in research synthesis of clinical trials. Stat Med. 1996 Aug;15(16):1713–28. [PubMed: 8870154]
56.
Morgenstern H. Uses of ecologic analysis in epidemiologic research. Am J Public Health. 1982 Dec;72(12):1336–44. [PMC free article: PMC1650553] [PubMed: 7137430]
57.
Morris CN, Normand SL. Hierarchical Models for Combining and for Meta-analyses. In: Bernardo JM, Berger JO, Dawid AP, et al., editors. Bayesian Biostatistcs 4. Oxford: University Press; 1992. p. 321–44.
58.
Mulrow C, Cook D, editors. Systematic reviews: synthesis of best evidence for health care decisions. Philadelphia, PA: American College of Physicians; 1998.
59.
Pauler DK, Wakefield J. Modeling and Implementation Issues in Bayesian and Meta-analysis. In: Stangl DK, Berry DB, editors. Meta-analysis in Medicine and Health Policy. New York: Marcel Dekker, Inc.; 2000. p. 205–30.
60.
Perry BH, Sampson AR, Schwab BH, et al. Personal communication to Morton SC. 2000. A meta-analytic approach to an integrated summary of efficacy: A case study of becaplermin gel. Available from Dr. AR Sampson. [PubMed: 12161082]
61.
Pladevall-Vila M, Delclos GL, Varas C. et al. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity. Am J Epidemiol. 1996 Jul;144(1):1–14. [PubMed: 8659479]
62.
Platt RW, Leroux BG, Breslow N. Generalized linear mixed models for meta-analysis. Stat Med. 1999 Mar;18(6):643–54. [PubMed: 10204195]
63.
Prevost TC, Abrams KR, Jones DR. Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening. Stat Med. 2000 Dec;19(23):3359–76. [PubMed: 11122501]
64.
Raudenbush SW. Random Effects Models. In: Cooper H, Hedges LV, editors. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994. p. 301–21.
65.
Rimm EB, Williams P, Fosher K. et al. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999 Dec;319(7224):1523–8. [PMC free article: PMC28294] [PubMed: 10591709]
66.
Schmid CH, Lau J, McIntosh MW. et al. An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials. Stat Med. 1998 Sep;17(17):1923–42. [PubMed: 9777687]
67.
Schmid CH. Exploring Heterogeneity in Randomized Trials Via Meta-analysis. Drug Information Journal. 1999;33:211–24.
68.
Sharp SJ, Thompson SG, Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. BMJ. 1996 Sep;313(7059):735–8. [PMC free article: PMC2352108] [PubMed: 8819447]
69.
Sharp SJ. Meta-analysis regression. STATA Technical Bulletin. 1998;42:16–22.
70.
Sharp SJ, Thompson SG. Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. Stat Med. 2000;19:3251–74. [PubMed: 11113958]
71.
Shea S, DuMouchel WH, Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J Am Med Inform Assoc. 2000 Nov;3(6):399–409. [PMC free article: PMC116324] [PubMed: 8930856]
72.
Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med. 1995 Dec;14(24):2685–99. [PubMed: 8619108]
73.
Smith TC, Abrams KR, Jones DR. Hierarchical Models in Generalised Synthesis of Evidence: An Example Based on Studies of Breast Cancer Screening. 16th International Society for Clinical Biostatistics Conference; 1995 Jul 31; Barcelona, Spain. Leicester (UK): University of Leicester; 1995. p. 3–32.
74.
Stuck AE, Siu AL, Wieland GD. et al. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet. 1993 Oct;342(8878):1032–6. [PubMed: 8105269]
75.
Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F; Methods for Meta-Analysis in Medical Research. Chichester, UK: John Wiley & Sons; 2000. Wiley Series in Probability and Statistics.
76.
Sutton AJ, Jones DR, Abrams KR. et al. Systematic reviews and meta-analysis: a structured review of the methodological literature. J Health Serv Res Policy. 1999 Jan;4(1):49–55. [PubMed: 10345567]
77.
Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med. 1997 Dec;16(23):2741–58. [PubMed: 9421873]
78.
Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999 Oct;18(20):2693–708. [PubMed: 10521860]
79.
Turner RM, Omar RZ, Yang M. et al. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med. 2000 Dec;19(24):3417–32. [PubMed: 11122505]
80.
Viswesvaran C, Sanchez JI. Moderator Search in Meta-analysis: A Review and Cautionary Note on Existing Approaches. Educational and Psychological Measurement. 1998 Feb;58(1):77–87.
81.
Walter SD. Variation in baseline risk as an explanation of heterogeneity in meta-analysis. Stat Med. 1997 Dec;16(24):2883–900. [PubMed: 9483721]
82.
Wieland D, Stuck AE, Siu AL. et al. Meta-analytic methods for health services research—an example from geriatrics. Eval Health Prof. 1995 Sep;18(3):252–82. [PubMed: 10145078]
83.
Zeegers MPA, Tan FES, Dorant E. et al. The impact of characteristics of cigarette smoking on urinary tract cancer risk, a meta-analysis of epidemiologic studies. Cancer. 2000 Aug;89(3):630–9. [PubMed: 10931463]
84.
Zhong L, Goldberg MS, Parent ME. et al. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer. 2000 Jan;27(1):3–18. [PubMed: 10672779]
85.
Zhou XH, Brizendine EJ, Pritz MB. Methods for combining rates from several studies. Stat Med. 1999 Mar;18(5):557–66. [PubMed: 10209811]
Bookshelf ID: NBK43901

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...